Atlas Trials

The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients

Clinical trial NCT04365517 · UNKNOWN

Trial details

NCT number
NCT04365517
Sponsor
University of Milan
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19Diabetes Mellitus, Type 2CKD
Start date
2021-12-29
Primary completion
2022-03-30
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.